Inhibiting c-MET diminishes neutrophil infiltration and retards tumor progression, demonstrating that c-MET inhibitors can potentially counteract neutrophil-mediated suppression of T cells, thereby synergizing with ICIs [34]. Here, MET is linked to neoplasm.